THUMPD3-AS1 Is Correlated With Non-Small Cell Lung Cancer And Regulates Self-Renewal Through miR-543 And ONECUT2

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2015;68:7–30. doi:10.3322/caac.21442
   Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Altorki NK, Markowitz GJ, Gao D, et al. The lung microenvironment: an important regulator of tumour growth and metastasis. Nat Rev Cancer. 2019;19(1):9–31.30532012
   PubMed Web of Science ®Google Scholar
• Vargas AJ, Harris CC. Biomarker development in the precision medicine era: lung cancer as a case study. Nat Rev Cancer. 2016;16(8):525–537. doi:10.1038/nrc.2016.5627388699
   PubMed Web of Science ®Google Scholar
• Abbosh C, Birkbak NJ, Swanton C. Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection. Nat Rev Clin Oncol. 2018;15(9):577–586. doi:10.1038/s41571-018-0058-329968853
   PubMed Web of Science ®Google Scholar
• Matsui M, Corey DR. Non-coding RNAs as drug targets. Nat Rev Drug Discov. 2017;16(3):167–179. doi:10.1038/nrd.2016.11727444227
   PubMed Web of Science ®Google Scholar
• Sun Q, Hao Q, Prasanth KV. Nuclear long noncoding RNAs: key regulators of gene expression. Trends Genet. 2018;34(2):142–157. doi:10.1016/j.tig.2017.11.00529249332
   PubMed Web of Science ®Google Scholar
• Greco S, Gaetano C, Martelli F. Long noncoding competing endogenous RNA networks in age-associated cardiovascular diseases. Int J Mol Sci. 2019;20(12):E3079. doi:10.3390/ijms2012307931238513
   PubMed Web of Science ®Google Scholar
• Yao RW, Wang Y, Chen LL. Cellular functions of long noncoding RNAs. Nat Cell Biol. 2019;21(5):542–551. doi:10.1038/s41556-019-0311-831048766
   PubMed Web of Science ®Google Scholar
• Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47–62. doi:10.1038/nrg.2015.1026666209
   PubMed Web of Science ®Google Scholar
• Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15(1):7–21. doi:10.1038/nrg360624296535
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang X, Chen W, et al. Regulatory roles of long noncoding RNAs implicated in cancer hallmarks. Int J Cancer. 2019. doi:10.1002/ijc.32277
   Web of Science ®Google Scholar
• Xie Y, Dang W, Zhang S, et al. The role of exosomal noncoding RNAs in cancer. Mol Cancer. 2019;18(1):37. doi:10.1186/s12943-019-0984-430849983
   PubMed Web of Science ®Google Scholar
• Osielska MA, Jagodziński PP. Long non-coding RNA as potential biomarkers in non-small-cell lung cancer: what do we know so far? Biomed Pharmacother. 2018;101:322–333. doi:10.1016/j.biopha.2018.02.09929499406
   PubMed Web of Science ®Google Scholar
• Ricciuti B, Mencaroni C, Paglialunga L, et al. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy. Med Oncol. 2016;33(2):18. doi:10.1007/s12032-016-0731-226786153
   PubMed Web of Science ®Google Scholar
• Li DS, Ainiwaer JL, Sheyhiding I, et al. Identification of key long non-coding RNAs as competing endogenous RNAs for miRNA-mRNA in lung adenocarcinoma. Eur Rev Med Pharmacol Sci. 2016;20(11):2285–2295.27338053
   PubMed Web of Science ®Google Scholar
• Ebert MS, Sharp PA. Emerging roles for natural microRNA sponges. Curr Biol. 2010;20:R858–R861. doi:10.1016/j.cub.2010.08.05220937476
   PubMed Web of Science ®Google Scholar
• Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272–283. doi:10.1038/nrg.2016.2027040487
   PubMed Web of Science ®Google Scholar
• Abdollahzadeh R, Daraei A, Mansoori Y, et al. Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer. J Cell Physiol. 2019;234(7):10080–10100. doi:10.1002/jcp.v234.730537129
   PubMed Web of Science ®Google Scholar
• Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344–352. doi:10.1038/nature1298624429633
   PubMed Web of Science ®Google Scholar
• Qi X, Zhang DH, Wu N, et al. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52(10):710–718. doi:10.1136/jmedgenet-2015-10333426358722
   PubMed Web of Science ®Google Scholar
• Fang L, Wu S, Zhu X, et al. MYEOV functions as an amplified competing endogenous RNA in promoting metastasis by activating TGF-β pathway in NSCLC. Oncogene. 2019;38(6):896–912. doi:10.1038/s41388-018-0484-930181549
   PubMed Web of Science ®Google Scholar
• Alam M, Ahmad R, Rajabi H, et al. MUC1-C induces the LIN28B→LET-7→HMGA2 axis to regulate self-renewal in NSCLC. Mol Cancer Res. 2015;13(3):449–460. doi:10.1158/1541-7786.MCR-14-036325368430
   PubMed Web of Science ®Google Scholar
• Treiber T, Treiber N, Meister G. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol. 2019;20(1):5–20. doi:10.1038/s41580-018-0059-130228348
   PubMed Web of Science ®Google Scholar
• Gebert LFR, MacRae IJ. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol. 2019;20(1):21–37.30108335
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203–222. doi:10.1038/nrd.2016.24628209991
   PubMed Web of Science ®Google Scholar
• Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2014;9:287–314. doi:10.1146/annurev-pathol-012513-10471524079833
   PubMed Web of Science ®Google Scholar
• Lu J, Zhan Y, Feng J, et al. MicroRNAs associated with therapy of non-small cell lung cancer. Int J Biol Sci. 2018;14(4):390–397. doi:10.7150/ijbs.2224329725260
   PubMed Web of Science ®Google Scholar
• Xu L, Yu J, Wang Z, et al. miR-543 functions as a tumor suppressor in glioma in vitro and in vivo. Oncol Rep. 2017;38(2):725–734. doi:10.3892/or.2017.571228627653
   PubMed Web of Science ®Google Scholar
• Liu X, Gan L, Zhang J. miR-543 inhibites cervical cancer growth and metastasis by targeting TRPM7. Chem Biol Interact. 2019;302:83–92. doi:10.1016/j.cbi.2019.01.03630710498
   PubMed Web of Science ®Google Scholar
• Chen P, Xu W, Luo Y, et al. MicroRNA 543 suppresses breast cancer cell proliferation, blocks cell cycle and induces cell apoptosis via direct targeting of ERK/MAPK. Onco Targets Ther. 2017;10:1423–1431. doi:10.2147/OTT28331335
   PubMed Web of Science ®Google Scholar
• Sapkota D, Chintala H, Wu F, et al. Onecut1 and Onecut2 redundantly regulate early retinal cell fates during development. Proc Natl Acad Sci USA. 2014;111(39):E4086–E4095. doi:10.1073/pnas.140535411125228773
   PubMed Web of Science ®Google Scholar
• Klimova L, Antosova B, Kuzelova A, et al. Onecut1 and Onecut2 transcription factors operate downstream of Pax6 to regulate horizontal cell development. Dev Biol. 2015;402(1):48–60. doi:10.1016/j.ydbio.2015.02.02325794677
   PubMed Web of Science ®Google Scholar
• Wu Y, Jiang G, Zhang N, et al. HOXA9, PCDH17, POU4F2, and ONECUT2 as a urinary biomarker combination for the detection of bladder cancer in chinese patients with hematuria. Eur Urol Focus. 2018;S2405–S4569(18):30289–X.
   Google Scholar
• Lu T, Wu B, Yu Y, et al. Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis. Cancer Sci. 2018;109(7):2221–2234. doi:10.1111/cas.1363329737581
   PubMed Web of Science ®Google Scholar
• Guo H, Ci X, Ahmed M, et al. ONECUT2 is a driver of neuroendocrine prostate cancer. Nat Commun. 2019;10(1):278. doi:10.1038/s41467-018-08133-630655535
   PubMedGoogle Scholar
• Rotinen M, You S, Yang J, et al. ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis. Nat Med. 2018;24(12):1887–1898. doi:10.1038/s41591-018-0241-130478421
   PubMed Web of Science ®Google Scholar
• Sun Y, Shen S, Liu X, et al. MiR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting onecut2 in colorectal carcinoma. Mol Cell Biochem. 2014;390(1–2):19–30. doi:10.1007/s11010-013-1950-x24402783
   PubMed Web of Science ®Google Scholar
• Shen M, Dong C, Ruan X, et al. Chemotherapy-induced extracellular vesicle mirnas promote breast cancer stemness by targeting ONECUT2. Cancer Res. 2019;79(14):3608–3621. doi:10.1158/0008-5472.CAN-18-405531118200
   PubMed Web of Science ®Google Scholar